SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ankr is a Web3 decentralized infrastructure provider that helps developers, dapps, and stakers easily interact with multiple blockchains. It allows you to create DApps using API and RPC, staking on Ankr Earn, and use customized blockchain solutions for businesses.

Ankr Network

Ankr is currently fueling intense debate among retail investors, as some community members point to its role as a fundamental infrastructure player for AI and Web3 as a reason to accumulate, while vocal critics dismiss the token as a stagnant, high-risk scam project. Sentiment remains heavily polarized between long-term holders hopeful for a resurgence fueled by upcoming network developments and frustrated participants who continue to call the asset a failed investment.

FUST (Fusion token) is the companion token of FUSD - with tokenomics which mirror those of a typical cryptocurrency. FUST can be placed in the FUST Fusion Miner and used to mine free FUSD. FUST has tokenomics which mirror those of a typical cryptocurrency, and allows those Degens who buy into the FUSD philosophy - but who also enjoy the thrill of chasing fast green candles - to make their play within the structure of the FUSD ecosystem and benefit from the best of both worlds; the possibility of a fast ride upwards whilst earning a passive income paid in our appreciating stable token courtesy of their FUST bag.

FUST Token

FUST is gaining momentum as investors pivot toward its ecosystem's unique passive income model, which aims to provide dividend-like returns through an appreciating stablecoin. The community is actively discussing the potential of this yield-generating system to redefine stablecoin utility by rewarding long-term holders rather than allowing value to stagnate.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors U.S. Big Oil 3 Leveraged ETNs

Bank of Montreal - MicroSectors U.S. Big Oil Index 3X Leveraged ETNs

The NRGU is gaining significant attention from investors amid heightened Middle East tensions and concerns over supply disruptions, which are propelling oil prices higher. Market participants are actively discussing the potential for a renewed rally in the energy sector, while also debating the long-term sustainability of leveraged positions against a backdrop of global economic uncertainty and shifting oil production narratives.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is seeing increased community buzz driven by rumors of a major collaboration with POL and its integration with ACH, leading investors to view it as a key privacy token poised to mirror the recent gains of Zcash. Traders are closely monitoring these developments as indicators of renewed utility and broader market strength for the asset.

Ubiquiti, Inc. engages in the business of selling equipment and provision of related software platforms. It operates through the Enterprise Technology and Service Provider Technology product categories. The company was founded by Robert J. Pera in October 2003 and is headquartered in New York, NY.

Ubiquiti Inc

Ubiquiti is capturing significant market attention following a record-breaking earnings report, where the company smashed quarterly revenue and EPS estimates while announcing a new $500 million share buyback and a dividend hike. The community is actively discussing the stock's massive short interest and low float, fueling speculation of a persistent short squeeze as institutional confidence in the company's enterprise market expansion continues to grow.

Irys is a Layer 1 datachain that unifies onchain data storage and smart contract execution into a single network. Traditional smart contract chains handle financial transactions but lack native primitives for working with data at scale. Traditional datachains handle storage but lack integration with smart contracts. Irys serves both. Irys bridges this gap by unifying storage and execution, making data programmable through IrysVM, its native EVM execution layer. The network offers flexible storage options: users can choose between term storage (temporary, duration-based) or permanent storage (one-time payment for perpetual retention). Both operate at at-cost pricing, made possible by Irys's multi-revenue model that combines storage fees, execution fees, and programmable data transactions. This design allows Irys to remain competitive on price while maintaining economic sustainability. Irys achieves instant data retrieval and infinite horizontal scaling. As demand grows, the network expands capacity by adding validators who prove continuous maintenance of their assigned data partitions. The network's native token, $IRYS, is used for all storage and execution fees, as well as validator staking.

Irys

Irys is gaining significant community attention driven by its integration into AI-focused narratives, with traders debating its potential for momentum-based rallies. While proponents highlight the protocol's programmable data chain features and supply dynamics, others express caution regarding price volatility and the influence of automated trading bots.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax (ABVX) is trending due to persistent and intensifying market speculation regarding a potential multibillion-dollar buyout by major pharmaceutical players like Eli Lilly and AstraZeneca. The community is actively debating the credibility of these rumors, analyzing potential acquisition premiums, and drawing parallels to previous biotech success stories while keeping a close eye on the company's recent pipeline progress and institutional activity.

Lamb Weston Holdings, Inc. engages in the production, distribution, and marketing of value-added frozen potato products. It operates through the North America and International segments. The North America segment includes frozen potato products sold in the United States, Canada, and Mexico to quick service and full-service restaurants and chains, foodservice distributors, non-commercial channels, and retailers. International segment primarily includes frozen potato products sold outside of North America. The company was founded in 1950 and is headquartered in Eagle, ID.

Lamb Weston Holdings Inc

Lamb Weston is currently the focus of significant market scrutiny following a major leadership overhaul, a downward revision to its annual outlook, and ongoing pressure from activist investor Jana Partners. Investors are closely monitoring the company's efforts to manage manufacturing costs and soft global demand while debating whether current valuation levels present an oversold opportunity for long-term recovery.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending as investors react to a significant $100 million insider purchase by a board member, fueling speculation about the company's long-term valuation and turnaround potential. Meanwhile, the community remains divided, with debates intensifying over whether the platform's heavy reliance on gig-worker labor and aggressive fee structures can remain sustainable amid rising competition and broader economic pressures.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

ShapeShift FOX token is seeing increased social sentiment as investors debate its potential as an undervalued DeFi asset compared to major decentralized exchanges, with community members actively discussing accumulation strategies and long-term price targets. While some participants express frustration over recent volatility and historical performance, many are closely monitoring technical indicators and BTC dominance trends in anticipation of a potential altcoin market expansion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. biotech stocks, particularly small and mid-cap companies, remained a focal point for retail investors in 2024 despite significant volatility.&nbsp;Collectively, biotech stocks on U.S. bourses have garnered over 3.3 million watchers on Stocktwits.&nbsp;Here are the top five biotech stocks that saw the most significant surge in new followers this year:CERo Therapeutics Holdings Inc. (CERO): +44544% WatchersThis immunotherapy company develops engineered T-cell therapeutics for cancer. <a href="https://stocktwits.com/symbol/CERO">CERO</a> saw major retail interest following the FDA’s clearance of its lead compound, CER-1236, for Phase 1 clinical trials after an earlier clinical hold. The company went public via a SPAC merger in February and has lost 99% of its value this year.Psyence Biomedical Ltd. (PBM): +6741% WatchersKnown for developing natural psilocybin products for treating psychological trauma, PBM gained attention for positive results from its Phase IIb trial in adjustment disorder treatment for terminal cancer patients.&nbsp;Its&nbsp;shares have also dropped 99% this year since the company’s March SPAC debut.Azitra Inc. (AZTR): +2365% WatchersSpecializing in dermatological therapies using engineered proteins and live biotherapeutic products, AZTR drew attention for securing&nbsp;a fast track designation for ATR-04 and other multiple&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-are-azitra-shares-trending-on-wednesday/c7r4UW0RbE">patents</a>. Its stock value has plunged more than 99% since its debut in June last year.Immuneering Corporation (IMRX): +2248% WatchersFocused on oncology, IMRX’s lead program, IMM-1-104, received FDA orphan drug designation for pancreatic cancer and fast-track status to treat certain melanoma patients, and is currently in a Phase 2a trial. <a href="https://stocktwits.com/symbol/IMRX">IMRX shares</a> have declined over 70% year-to-date.NKGen Biotech Inc. (NKGN): +1260% WatchersNKGN develops autologous and CAR-NK cell therapies. Its SNK01 natural killer cell therapy for Alzheimer’s disease showed promising results, with 90% of patients maintaining or improving cognitive function. The candidate was cleared to progress into phase 2 clinical development, which will involve a larger group of 30 patients with moderate Alzheimer's disease. Shares, however, have fallen more than 66% this year.Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments, positioning them as key biotech names to watch heading into 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Woman examining laboratory samples - stock photo | Image source: Getty Images

Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024

Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments.

Equity

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.

NKGN
NKGen Biotech Inc

Feed

News

Sentiment

Fundamentals

Info

Latest NKGN News

NKGNNKGen Biotech Inc